肿瘤组织侵袭性的影像学:基于组织灌注的新生血管、血管拟态与分子交换
本文综述了健康组织与恶性肿瘤中血管生成的差异,指出血管拟态形成可改变对比剂或放射性药物的分布,毛细血管壁分子交换失败影响其行为。恶性肿瘤的指示性征象包括通透性增加和细胞外与血管内间隙间更快的分子交换,动态成像可评估这些微环境变化。肿瘤发展和侵袭性可基于血管床发育变化、组织内分子交换水平及器官内特征性分布来评估,杂交成像(含PET/MRI)可量化血管化并优化治疗前评估及抗血管生成治疗疗效评价。
要点
- 动态成像可评估肿瘤微环境中通透性增加和分子交换加快,提示恶性组织。
- 血管拟态形成改变对比剂或放射性药物分布,影响影像模式解读。
- 杂交成像(PET/MRI)可量化血管化,助于治疗前评估和抗血管生成疗效评价。
关键影像表现/征象
- 恶性肿瘤组织通透性增加,细胞外与血管内间隙间分子交换加快。
- 血管拟态形成导致对比剂或放射性药物分布改变。
- 肿瘤形成早期血流再分布反映新发微环境条件。
临床应用与阅片要点
- 阅片时关注动态成像中对比剂分布和分子交换变化,辅助判断肿瘤侵袭性。
- 理解血管拟态可导致影像模式不典型,避免仅凭常规增强模式排除恶性。
- 杂交PET/MRI可用于量化血管化,优化治疗前评估和抗血管生成治疗疗效监测。
局限性
- 本文为综述,未报告系统检索策略、纳入文献数量及证据分级。
- 未提供具体敏感度、特异度、AUC或阈值等诊断性能数据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Angiogenesis in healthy tissue and within malignant tumors differs on many levels, which may partly be explained by vascular mimicry formation resulting in altered contrast material or different radiopharmaceuticals distributions. Failed remodulation results in changes in the molecular exchange through the capillary wall and those consequences affect the behavior of contrast agents and radiopharmaceuticals. One of the most indicative signs of malignant tissue is the increased permeability and the faster molecular exchange that occurs between the extracellular and intravascular spaces. Dynamic imaging can help to assess the changed microenvironment. The fast-distribution of molecules reflects newly developed conditions in blood-flow redistribution inside a tumor and within the affected organ during the early stages of tumor formation. Tumor development, as well as aggressiveness, can be assessed based on the change to the vascular bed development, the level of molecular exchange within the tissue, and/or indicative distribution within the organ. The study of the vascular network organization and its impact on the distribution of molecules is important to our understanding of the image pattern in several imaging methods, which in turn influences our interpretation of the findings. A hybrid imaging approach (including PET/MRI) allows the quantification of vascularization and/or its pathophysiological impressions in structural and metabolic images. It might optimize the evaluation of the pretreatment imaging, as well as help assess the effect of therapy targeting neovascularization; antiVEGF drugs and embolization-based therapies, for example.
引用
- Ferda, Frölich, Ferdová, et al. Neovascularization, vascular mimicry and molecular exchange: The imaging of tumorous tissue aggressiveness based on tissue perfusion. Eur J Radiol. 2023. PMID: 37018901. doi:10.1016/j.ejrad.2023.110797
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。